Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schollmeyer

Showing results (21-30 of 288) with videos related to

Pageof 29
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 1, 1989
[Pathogenesis, diagnosis and therapy of type IV renal tubular acidosis]K W Dreyling, P Schollmeyer
Nephron|February 7, 1998
Adequate management of heparin-associated thrombocytopeniaK G Fischer, P Schollmeyer
Klinische Wochenschrift|August 1, 1983
Inhibition of salvage pathway enzymes by adenine arabinoside 5'-monophosphate (ara-AMP)H J Becher, P Schollmeyer
Kidney International|February 1, 1986
Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysisH B Steinhauer, P Schollmeyer
Klinische Wochenschrift|September 1, 1989
[Modulation of renal transmitter release by presynaptic receptors]L C Rump, P Schollmeyer
Advances in Experimental Medicine and Biology|January 1, 1993
C-ANCA and p-ANCA positive vasculitis with crescentic glomerulonephritis: the same clinical feature but different immunological pathways?W Grotz, E Röther, P Schollmeyer
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1976
[Studies on the behavior of liver glycogen in uremia]J Fröhlich, P Schollmeyer, W Gerok
Clinical Pharmacokinetics|February 1, 1990
Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetic considerationsE Keller, P Reetze, P Schollmeyer
Medizinische Klinik (Munich, Germany : 1983)|November 15, 1996
[Therapy with antibiotics in renal failure]K Anding, B Krumme, P Schollmeyer
European Journal of Clinical Pharmacology|January 1, 1987
Kinetics of ceftazidime during plasmapheresisF Bozkurt, P Schollmeyer, E Keller
Pageof 29

Showing results (21-30 of 288) with videos related to

Sort By:
Pageof 29
Deutsche Medizinische Wochenschrift (1946)|September 1, 1989
[Pathogenesis, diagnosis and therapy of type IV renal tubular acidosis]K W Dreyling, P Schollmeyer
Nephron|February 7, 1998
Adequate management of heparin-associated thrombocytopeniaK G Fischer, P Schollmeyer
Klinische Wochenschrift|August 1, 1983
Inhibition of salvage pathway enzymes by adenine arabinoside 5'-monophosphate (ara-AMP)H J Becher, P Schollmeyer
Kidney International|February 1, 1986
Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysisH B Steinhauer, P Schollmeyer
Klinische Wochenschrift|September 1, 1989
[Modulation of renal transmitter release by presynaptic receptors]L C Rump, P Schollmeyer
Advances in Experimental Medicine and Biology|January 1, 1993
C-ANCA and p-ANCA positive vasculitis with crescentic glomerulonephritis: the same clinical feature but different immunological pathways?W Grotz, E Röther, P Schollmeyer
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1976
[Studies on the behavior of liver glycogen in uremia]J Fröhlich, P Schollmeyer, W Gerok
Clinical Pharmacokinetics|February 1, 1990
Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetic considerationsE Keller, P Reetze, P Schollmeyer
Medizinische Klinik (Munich, Germany : 1983)|November 15, 1996
[Therapy with antibiotics in renal failure]K Anding, B Krumme, P Schollmeyer
European Journal of Clinical Pharmacology|January 1, 1987
Kinetics of ceftazidime during plasmapheresisF Bozkurt, P Schollmeyer, E Keller
Pageof 29